The Ischemic Stroke Market growth continues to gain traction as pharmaceutical pipelines target novel molecular pathways involved in ischemia-reperfusion injury and neuroinflammation. With the global burden of ischemic stroke projected to rise substantially over the coming decades due to demographic shifts and lifestyle disease epidemics, the demand for disease-modifying therapies beyond...